We hereby submit the intimation of Contact details of KMP pursuant to Regulation 30(5) of SEBI(LODR) Regulations, 2025.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-9.0%1-day move

₹363.05

prior close

₹381.20

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0+0.0-9.0-13.5-9.2-12.9-8.6—-39.4-38.9-45.2—

Up moveDown movePending

AI summary

Speciality Medicines Ltd has filed an intimation with BSE regarding the contact details of Key Managerial Personnel (KMPs) authorized under SEBI regulations. The company's Board meeting held on April 28, 2026 designated three KMPs for investor communication purposes. Mr. Parthkumar Babulal Goyani (Chairman & MD) is authorized to determine materiality of events, while Ms. Anita Kumawat (Company Secretary & Compliance Officer) is authorized to make disclosures of material events. The company also provided contact numbers and email addresses for investor queries.

Likely market impact

This is a routine compliance filing that updates investor contact information. It has no direct impact on the stock price or operations, but ensures proper channels exist for shareholder and regulatory communications.